Stay updated on Deucravacitinib Efficacy in Active Psoriatic Arthritis Clinical Trial

Sign up to get notified when there's something new on the Deucravacitinib Efficacy in Active Psoriatic Arthritis Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Deucravacitinib Efficacy in Active Psoriatic Arthritis Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2.
    Difference
    0.0%
    Check dated 2025-04-30T13:57:41.000Z thumbnail image
  4. Check
    28 days ago
    No Change Detected
  5. Check
    35 days ago
    Change Detected
    Summary
    The webpage has been updated to include new results and metrics related to the efficacy and safety of a treatment for psoriatic arthritis, including specific participant outcomes and assessment scores. Notably, the location of the study has changed from Szarvas, Hungary to Hódmezővásárhely, Hungary.
    Difference
    100%
    Check dated 2025-04-16T02:18:51.000Z thumbnail image
  6. Check
    42 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.14.3 to version 2.14.4.
    Difference
    0.1%
    Check dated 2025-04-08T23:55:09.000Z thumbnail image
  7. Check
    49 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.14.2 to version 2.14.3.
    Difference
    0.1%
    Check dated 2025-04-01T19:02:06.000Z thumbnail image
  8. Check
    78 days ago
    Change Detected
    Summary
    The page has removed a notice about heavy traffic affecting certain services and products, as well as a message indicating that no results were posted. Additionally, a new message stating 'Results Submitted' has been added.
    Difference
    1%
    Check dated 2025-03-03T22:24:15.000Z thumbnail image
  9. Check
    100 days ago
    Change Detected
    Summary
    The web page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.
    Difference
    1.0%
    Check dated 2025-02-10T09:57:55.000Z thumbnail image

Stay in the know with updates to Deucravacitinib Efficacy in Active Psoriatic Arthritis Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Deucravacitinib Efficacy in Active Psoriatic Arthritis Clinical Trial page.